WebNov 14, 2016 · About BioSyent Inc. Listed on the TSX Venture Exchange under the trading symbol "RX", BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical products that have been successfully developed, are safe and effective, and have a proven track record of … WebMar 21, 2024 · About BioSyent Inc. Listed on the TSX Venture Exchange under the trading symbol “RX”, BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical and other healthcare products that have been successfully developed, are safe and effective, and have a …
BioSyent Inc. (CVE:RX) On An Uptrend: Could Fundamentals Be …
WebDec 23, 2004 · Biosyent Inc has listed on the Toronto Venture Exchange (TSX-V) under the ticker RX. Trading volume was 5,300 on 11 total trades, with an average volume of 5,783 over 5 days. WebHealth Sciences graduate from Simon Fraser University with over 8 years of experience in data-driven pharmaceutical, medical and retail sales with a proven track record and an entrepreneurial spirit. Currently representing BioSyent’s innovative lineup of products available in the Canadian and abroad pharmaceutical markets while building and … philly cheese stick
FAX Capital Announces Investment in BioSyent Inc., Files
WebDiscover historical prices for BIOYF stock on Yahoo Finance. View daily, weekly or monthly format back to when BioSyent Inc. stock was issued. WebFind the latest BioSyent Inc. (RX.V) stock quote, history, news and other vital information to help you with your stock trading and investing. WebNov 15, 2012 · TORONTO, ONTARIO--(Marketwire - Nov 15, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its Third Quarter (Q3) 2012 financial results. - Q3 2012 Sales of $1,575,598 sets an all time quarterly record and grew by 60% over Q3 2011 tsa scanner images bags